My HPRA: Register

LIFSAR PULMOJET

50/500 Microgram Powder for Inhalation

Sanofi-Aventis Ireland Limited T/A SANOFIPA0540/174/001

Main Information

Trade NameLIFSAR PULMOJET
Active SubstancesSALMETEROL XINAFOATE
FLUTICASONE PROPIONATE
Strength50/500 Microgram
Dosage FormPowder for Inhalation
Licence HolderSanofi-Aventis Ireland Limited T/A SANOFI
Licence NumberPA0540/174/001

Group Information

ATC CodeR03AK06 Adrenergics in combination with corticosteroids or other drugs, excl. Anticholinergics

Status

Authorised/WithdrawnAuthorised
Licence Issued27/11/2015
Supply StatusSupply through pharmacies only
Dispensing StatusProduct subject to prescription which may be renewed (B)
Marketing StatusNot Marketed
Promotion StatusPromotion to Healthcare Professionals only
Conditions of Licence

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back
Follow medicine

Print

Summary of Product Characteristics

View More SPC Headings

Latest Changes to Medicine Info & SPC

View all available

Please note changes to the medicine information and summary of product characteristics are only available from the 19/05/2015 onwards. Changes made before this date aren't available online.